DHA medical, r & d contract sbir 2ND phase II, proposal#: H2-0402, titled, " aligned nanofibrillar scaffold activated with HGF-mmrna in combination with minced muscle graft for treating volumetric…
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH19C0021
- Awardee
-
Fibralign Corporation UEI SKHKN4KZAE48
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $996,609
Award facts
- Opportunity
-
- HQ003418R1CDB Solicitation number
- Contract value 100% obligated
- $996,609.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Union City, CA 94587, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $996,609 |
About this award
The Department of the Army Medical Command awarded a $996,609.36 Small Business Innovation Research (SBIR) Phase II contract to Fibralign Corporation, a self-certified small disadvantaged business. The contract is for the development of an "Aligned Nanofibrillar Scaffold Activated with HGF-mRNA in Combination with Minced Muscle Graft for Treating Volumetric Muscle Loss (VML) Injury". This research and development work is being conducted under the Major Program Code S10. The contract has a firm fixed-price pricing type and a completion date of October 6, 2022.
Description
DHA medical, r & d contract sbir 2ND phase II, proposal#: H2-0402, titled, " aligned nanofibrillar scaffold activated with HGF-mmrna in combination with minced muscle graft for treating volumetric muscle loss (VML) injury"
Quick answers
Who was awarded contract W81XWH19C0021?
W81XWH19C0021 was awarded to Fibralign Corporation by Medical Command (Department of the Army) on February 7, 2019.
How much is contract W81XWH19C0021 worth?
The government has obligated $996,609 on W81XWH19C0021.
Was contract W81XWH19C0021 competed?
The extent of competition for W81XWH19C0021 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award